Archives: Resources

Explore how centralized ECG data collection improves consistency, safety oversight and regulatory readiness in clinical trials.

Discover how innovative endpoints in early phase oncology trials support earlier insights across efficacy, safety and patient experience.

Explore how diverse endpoint strategies allow sponsors to assess safety, efficacy and broader health impacts in obesity and GLP-1 trials.

Explore how early scientific engagement enables biotechs to optimize trial design, endpoint strategy, data quality and regulatory planning.

Explore how patient-reported outcomes and eCOA strategy capture quality-of-life data that differentiates oncology treatments.

Explore how cognitive assessments and wearable sensor-based gait measures are being studied in Alzheimer’s disease and mild cognitive impairment.

Explore imaging, cardiac safety, eCOA and adjudication services that support high-quality endpoint data in neuroscience clinical trials.

Discover endpoint strategies for GLP-1 trials, including FDA guidance, clinical adjudication and imaging approaches for drug differentiation.

Discover how rapid eCOA setup supported study timelines, site readiness and enrollment in a global Phase III chronic weight management trial.